We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESV
101
DELISTED
Ensco Rowan plc
ESV
| $6.06M | 0.22% |
107,537
+35,824
| +50% | +$2.47M |
|
102
Applied Materials
AMAT
$410B
| $6.04M | 0.22% |
410,876
-24,148
| -6% | -$403K |
|
103
AT&T
T
$167B
| $5.96M | 0.22% |
+242,247
| New | +$6.18M |
|
|
DNKN
104
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $5.84M | 0.22% |
119,160
+78,511
| +193% | +$4.07M |
|
105
KeyCorp
KEY
$24.1B
| $5.78M | 0.21% |
444,435
-18,108
| -4% | -$257K |
|
106
Constellation Brands
STZ
$22.2B
| $5.78M | 0.21% |
+46,119
| New | +$5.69M |
|
|
TERP
107
DELISTED
TerraForm Power, Inc
TERP
| $5.76M | 0.21% |
405,347
+279,290
| +222% | +$7.48M |
|
108
PG&E
PCG
$47.2B
| $5.75M | 0.21% |
+108,849
| New | +$5.56M |
|
109
AerCap
AER
$23.9B
| $5.72M | 0.21% |
149,484
+48,960
| +49% | +$2.16M |
|
110
Mondelez International
MDLZ
$77.9B
| $5.7M | 0.21% |
136,070
-78,678
| -37% | -$3.39M |
|
|
CAM
111
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $5.67M | 0.21% |
92,486
-20,817
| -18% | -$1.15M |
|
112
Ionis Pharmaceuticals
IONS
$9.25B
| $5.63M | 0.21% |
139,383
-26,975
| -16% | -$1.4M |
|
|
SKX
113
DELISTED
Skechers
SKX
| $5.63M | 0.21% |
126,015
-73,830
| -37% | -$3.35M |
|
114
JetBlue
JBLU
$2.02B
| $5.63M | 0.21% |
218,481
-336,494
| -61% | -$7.93M |
|
115
Edwards Lifesciences
EW
$47.8B
| $5.6M | 0.21% |
236,382
-266,628
| -53% | -$6.44M |
|
|
LM
116
DELISTED
Legg Mason, Inc.
LM
| $5.55M | 0.21% |
133,507
+59,201
| +80% | +$2.74M |
|
117
T-Mobile US
TMUS
$190B
| $5.54M | 0.21% |
139,036
+107,811
| +345% | +$4.3M |
|
|
ETFC
118
DELISTED
E*Trade Financial Corporation
ETFC
| $5.5M | 0.2% |
208,956
+140,688
| +206% | +$3.9M |
|
119
Novavax
NVAX
$1.23B
| $5.46M | 0.2% |
+38,595
| New | +$8.65M |
|
120
Invesco
IVZ
$13.3B
| $5.45M | 0.2% |
174,405
+16,842
| +11% | +$599K |
|
121
Adobe
ADBE
$94.5B
| $5.43M | 0.2% |
+66,103
| New | +$5.36M |
|
|
RDC
122
DELISTED
Rowan Companies Plc
RDC
| $5.41M | 0.2% |
334,947
+91,973
| +38% | +$1.6M |
|
123
Nucor
NUE
$56.4B
| $5.39M | 0.2% |
143,519
+37,722
| +36% | +$1.62M |
|
|
CIE
124
DELISTED
Cobalt International Energy, Inc
CIE
| $5.36M | 0.2% |
50,464
+27,014
| +115% | +$3.29M |
|
|
N
125
DELISTED
Netsuite Inc
N
| $5.33M | 0.2% |
63,484
+49,710
| +361% | +$4.57M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.